Kater AP - Search Results

1

ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia.

Pospisilova S, Gonzalez D, Malcikova J, Trbusek M, Rossi D, Kater AP, Cymbalista F, Eichhorst B, Hallek M, Döhner H, Hillmen P, van Oers M, Gribben J, Ghia P, Montserrat E, Stilgenbauer S, Zenz T; European Research Initiative on CLL (ERIC). Pospisilova S, et al. Among authors: kater ap. Leukemia. 2012 Jul;26(7):1458-61. doi: 10.1038/leu.2012.25. Epub 2012 Feb 2. Leukemia. 2012. PMID: 22297721 Review.

2

[Chronic lymphocytic leukemia: high time for a risk-adapted approach].

Kater AP, van Oers MH. Kater AP, et al. Ned Tijdschr Geneeskd. 2003 Jan 18;147(3):104-9. Ned Tijdschr Geneeskd. 2003. PMID: 12577769 Review. Dutch.

3

Autologous cytomegalovirus-specific T cells as effector cells in immunotherapy of B cell chronic lymphocytic leukaemia.

Kater AP, Remmerswaal EB, Nolte MA, Eldering E, van Oers MH, van Lier RA. Kater AP, et al. Br J Haematol. 2004 Aug;126(4):512-6. doi: 10.1111/j.1365-2141.2004.05070.x. Br J Haematol. 2004. PMID: 15287944 Free article.

4

Chronic lymphocytic leukemia cells display p53-dependent drug-induced Puma upregulation.

Mackus WJ, Kater AP, Grummels A, Evers LM, Hooijbrink B, Kramer MH, Castro JE, Kipps TJ, van Lier RA, van Oers MH, Eldering E. Mackus WJ, et al. Among authors: kater ap. Leukemia. 2005 Mar;19(3):427-34. doi: 10.1038/sj.leu.2403623. Leukemia. 2005. PMID: 15674362

5

Differential Noxa/Mcl-1 balance in peripheral versus lymph node chronic lymphocytic leukemia cells correlates with survival capacity.

Smit LA, Hallaert DY, Spijker R, de Goeij B, Jaspers A, Kater AP, van Oers MH, van Noesel CJ, Eldering E. Smit LA, et al. Among authors: kater ap. Blood. 2007 Feb 15;109(4):1660-8. doi: 10.1182/blood-2006-05-021683. Epub 2006 Oct 12. Blood. 2007. PMID: 17038534 Free article.

6

Cellular immune therapy for chronic lymphocytic leukemia.

Kater AP, van Oers MH, Kipps TJ. Kater AP, et al. Blood. 2007 Oct 15;110(8):2811-8. doi: 10.1182/blood-2007-01-068932. Epub 2007 Jul 16. Blood. 2007. PMID: 17638850 Free article. Review.

7

No convincing evidence for a role of CD31-CD38 interactions in the pathogenesis of chronic lymphocytic leukemia.

Tonino SH, Spijker R, Luijks DM, van Oers MH, Kater AP. Tonino SH, et al. Among authors: kater ap. Blood. 2008 Aug 1;112(3):840-3. doi: 10.1182/blood-2008-03-144576. Epub 2008 Jun 2. Blood. 2008. PMID: 18519815 Free article.

8

miR-34a as part of the resistance network in chronic lymphocytic leukemia.

Zenz T, Mohr J, Eldering E, Kater AP, Bühler A, Kienle D, Winkler D, Dürig J, van Oers MH, Mertens D, Döhner H, Stilgenbauer S. Zenz T, et al. Among authors: kater ap. Blood. 2009 Apr 16;113(16):3801-8. doi: 10.1182/blood-2008-08-172254. Epub 2008 Oct 21. Blood. 2009. PMID: 18941118 Free article.

9

In vivo dynamics of stable chronic lymphocytic leukemia inversely correlate with somatic hypermutation levels and suggest no major leukemic turnover in bone marrow.

van Gent R, Kater AP, Otto SA, Jaspers A, Borghans JA, Vrisekoop N, Ackermans MA, Ruiter AF, Wittebol S, Eldering E, van Oers MH, Tesselaar K, Kersten MJ, Miedema F. van Gent R, et al. Among authors: kater ap. Cancer Res. 2008 Dec 15;68(24):10137-44. doi: 10.1158/0008-5472.CAN-08-2325. Cancer Res. 2008. PMID: 19074880

10

Detection of p53 dysfunction in chronic lymphocytic leukaemia cells through multiplex quantification of p53 target gene induction.

Mous R, Jaspers A, Luijks DM, Mellink CH, van Oers MH, Kater AP, Eldering E. Mous R, et al. Among authors: kater ap. Leukemia. 2009 Jul;23(7):1352-5. doi: 10.1038/leu.2009.71. Epub 2009 Apr 2. Leukemia. 2009. PMID: 19340003 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

229 results

Search Page

Filters